GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds … – MarketWatch

« « Rate of Diabetes Cases Doubles in 10 Years: CDC – U.S. News & World Report  |  Saturday event helps those living with diabetes – Tulsa World » »

GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds … – MarketWatch

Friday, October 31st, 2008    Subscribe To Our Feed


SmartAboutHealth

GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds
MarketWatch?- 5 hours ago
AVANDIA has been shown to be a safe and highly effective treatment for type 2 diabetes for the appropriate patient. GSK strongly supports the safety and
Consumer Group Seeks FDA Ban on Avandia U.S. News & World Report
Consumer Group Seeks FDA Ban of Glaxo's Avandia Wall Street Journal
Liver risk, death seen with Glaxo's Avandia: group Reuters
RTT News?- eMaxHealth.com
all 124 news articles

Source:GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds … – MarketWatch

No Tags

Share and Enjoy:
  • Digg
  • Furl
  • del.icio.us
  • Slashdot
  • Smarking
  • NewsVine
  • SphereIt
  • blinkbits
  • Reddit
  • Blue Dot
  • StumbleUpon
  • BlinkList
  • Spurl
  • Netscape

Posted in insulin | | Top Of Page



Site Search Tags: No Tags
Technorati Tags: No Tags
Related Tags: No Tags


Possible Related Posts

Fingertips are More Accurate for Glucose TestingExercise Can Help Reduce Liver Fat LevelsReal-Life Stories of Diabetes Success – MarketWatch

Leave a Reply

Comment moderation is enabled. Your comment may take some time to appear.